Person Prof David Ashley National Health and Medical Research Council Viewed: [[ro.stat.viewed]] Click to explore relationships graph Help Related Grants and Projects Participant in A 2:1 Randomised Phase II Study of NivolUmab and Temozolomide vs Temozolomide in Methylated newly diagnosed Elderly Glioblastoma (NUTMEG) (funded by National Health and Medical Research Council) Participant in A Multi-Centre Randomised Controlled Trial to Test the Efficacy and Cost Effectiveness of an Intervention to Reduce Carer Burden and Depression among Caregivers of Cancer Patients (funded by National Health and Medical Research Council) Participant in A National Case-Control Study of the Causes of Childhood Brain Tumours (funded by National Health and Medical Research Council) Principal investigator of A Novel Approach to Immune Reconstruction And Dendritic Cell Vaccination After Intensive Chemotherapy In Neuroblastoma (funded by National Health and Medical Research Council) Participant in, Principal investigator of A Phase II Study of continuous, low-dose LBH 589 (Panobinostat) in Patients with Refractory Solid Tumors, including CNS tumors (funded by National Health and Medical Research Council) View all 10 related grants and projects User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover Saved to MyRDA Save to MyRDA
Click to explore relationships graph Help Related Grants and Projects Participant in A 2:1 Randomised Phase II Study of NivolUmab and Temozolomide vs Temozolomide in Methylated newly diagnosed Elderly Glioblastoma (NUTMEG) (funded by National Health and Medical Research Council) Participant in A Multi-Centre Randomised Controlled Trial to Test the Efficacy and Cost Effectiveness of an Intervention to Reduce Carer Burden and Depression among Caregivers of Cancer Patients (funded by National Health and Medical Research Council) Participant in A National Case-Control Study of the Causes of Childhood Brain Tumours (funded by National Health and Medical Research Council) Principal investigator of A Novel Approach to Immune Reconstruction And Dendritic Cell Vaccination After Intensive Chemotherapy In Neuroblastoma (funded by National Health and Medical Research Council) Participant in, Principal investigator of A Phase II Study of continuous, low-dose LBH 589 (Panobinostat) in Patients with Refractory Solid Tumors, including CNS tumors (funded by National Health and Medical Research Council) View all 10 related grants and projects User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover
